Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Kim, Seok J ^a   Choi, Chul W ^b   Mun, Yeung Chul ^c   Oh, Sung Y ^d   Kang, Hye J ^e   Lee, Soon I ^f   Won, Jong H ^g   Kim, Min K ^h   Kwon, Jung H ⁱ   Kim, Jin S ^j   Kwak, Jae Yong ^a   Kwon, Jung M ^b   Hwang, In G ^c   Kim, Hyo J ^d   Lee, Jae H ^e   Oh, Sukjoong ^f   Park, Keon W ^f   Suh, Cheolwon ^g   Kim, Won S ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

^d Dong A University College of Medicine   (South Korea)

^e Korea Cancer Center Hospital   (South Korea)

^f Dankook University College of Medicine   (South Korea)

^g Soonchunhyang University College of Medicine   (South Korea)

^h Yeungnam University College of Medicine   (South Korea)

ⁱ Hallym University College of Medicine   (South Korea)

^j NONE

more..

Author keywords

Histopathology; Intestine; Non Hodgkin lymphomaprognosis

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COLONOSCOPY; CONTROLLED STUDY; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; FEMALE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; INTESTINE LYMPHOMA; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NK T CELL LYMPHOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL T CELL LYMPHOMA; PHENOTYPE; PRIMARY TUMOR; PROGNOSIS; RETROSPECTIVE STUDY; T CELL LYMPHOMA; TISSUE DISTRIBUTION; CLASSIFICATION; CLINICAL TRIAL; INTESTINE TUMOR; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTESTINAL NEOPLASMS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79960883662     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-321     Document Type: Article

References (32)

1. d'Amore F, Brincker H, Gronbaek K, Thorling K, Pedersen M, Jensen MK, Andersen E, Pedersen NT, Mortensen LS. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol 1994, 12(8):1673-1684.
2. Ko YH, Kim CW, Park CS, Jang HK, Lee SS, Kim SH, Ree HJ, Lee JD, Kim SW, Huh JR. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 1998, 83(4):806-812.
3. Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer 2003, 97(10):2462-2473. 10.1002/cncr.11415, 12733145.
4. Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, Grothaus-Pinke B, Reinartz G, Brockmann J, Temmesfeld A, et al. Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 2001, 19(18):3861-3873.
5. Zinzani PL, Magagnoli M, Pagliani G, Bendandi M, Gherlinzoni F, Merla E, Salvucci M, Tura S. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients. Haematologica 1997, 82(3):305-308.
6. Kohno S, Ohshima K, Yoneda S, Kodama T, Shirakusa T, Kikuchi M. Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification. Histopathology 2003, 43(2):135-143. 10.1046/j.1365-2559.2003.01659.x, 12877728.
7. Lee J, Kim WS, Kim K, Ko YH, Kim JJ, Kim YH, Chun HK, Lee WY, Park JO, Jung CW, et al. Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leuk Lymphoma 2004, 45(2):339-344. 10.1080/10428190310001593111, 15101721.
8. Wong MT, Eu KW. Primary colorectal lymphomas. Colorectal Dis 2006, 8(7):586-591. 10.1111/j.1463-1318.2006.01021.x, 16919111.
9. Li B, Shi YK, He XH, Zou SM, Zhou SY, Dong M, Yang JL, Liu P, Xue LY. Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients. Int J Hematol 2008,
10. Kako S, Oshima K, Sato M, Terasako K, Okuda S, Nakasone H, Yamazaki R, Tanaka Y, Tanihara A, Kawamura Y, et al. Clinical outcome in patients with small intestinal non-Hodgkin lymphoma. Leuk Lymphoma 2009, 1-7.
11. Kim YH, Lee JH, Yang SK, Kim TI, Kim JS, Kim HJ, Kim JI, Kim SW, Kim JO, Jung IK, et al. Primary colon lymphoma in Korea: a KASID (Korean Association for the Study of Intestinal Diseases) Study. Dig Dis Sci 2005, 50(12):2243-2247. 10.1007/s10620-005-3041-7, 16416168.
12. Yin L, Chen CQ, Peng CH, Chen GM, Zhou HJ, Han BS, Li HW. Primary small-bowel non-Hodgkin's lymphoma: a study of clinical features, pathology, management and prognosis. J Int Med Res 2007, 35(3):406-415.
13. Amer MH, el-Akkad S. Gastrointestinal lymphoma in adults: clinical features and management of 300 cases. Gastroenterology 1994, 106(4):846-858.
14. Domizio P, Owen RA, Shepherd NA, Talbot IC, Norton AJ. Primary lymphoma of the small intestine. A clinicopathological study of 119 cases. Am J Surg Pathol 1993, 17(5):429-442. 10.1097/00000478-199305000-00001, 8470758.
15. Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, Grothaus-Pinke B, Reinartz G, Brockmann J, Temmesfeld A, et al. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma--results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol 2001, 19(18):3874-3883.
16. Daum S, Ullrich R, Heise W, Dederke B, Foss HD, Stein H, Thiel E, Zeitz M, Riecken EO. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. J Clin Oncol 2003, 21(14):2740-2746. 10.1200/JCO.2003.06.026, 12860953.
17. Gurney KA, Cartwright RA, Gilman EA. Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer 1999, 79(11-12):1929-1934. 2362786, 10206316.
18. Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer 1978, 42(2):693-707. 10.1002/1097-0142(197808)42:2<693::AID-CNCR2820420241>3.0.CO;2-J, 354774.
19. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol 1994, 25(10):1020-1029. 10.1016/0046-8177(94)90060-4, 7927306.
20. Rohatiner A, d'Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, Lister TA, Norton A, Salem P, Shipp M, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994, 5(5):397-400.
21. Cortelazzo S, Rossi A, Oldani E, Motta T, Giardini R, Zinzani PL, Zucca E, Gomez H, Ferreri AJ, Pinotti G, et al. The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B-cell and diffuse large B-cell histologies. Br J Haematol 2002, 118(1):218-228. 10.1046/j.1365-2141.2002.03613.x, 12100151.
22. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981, 47(1):207-214. 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6, 7459811.
23. Koch P, Probst A, Berdel WE, Willich NA, Reinartz G, Brockmann J, Liersch R, del Valle F, Clasen H, Hirt C, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol 2005, 23(28):7050-7059. 10.1200/JCO.2005.04.031, 16129843.
24. Nakamura S, Matsumoto T, Takeshita M, Kurahara K, Yao T, Tsuneyoshi M, Iida M, Fujishima M. A clinicopathologic study of primary small intestine lymphoma: prognostic significance of mucosa-associated lymphoid tissue-derived lymphoma. Cancer 2000, 88(2):286-294. 10.1002/(SICI)1097-0142(20000115)88:2<286::AID-CNCR7>3.0.CO;2-Z, 10640959.
25. Zucca E, Roggero E, Pinotti G, Pedrinis E, Cappella C, Venco A, Cavalli F. Patterns of survival in mantle cell lymphoma. Ann Oncol 1995, 6(3):257-262.
26. Pinotti G, Zucca E, Roggero E, Pascarella A, Bertoni F, Savio A, Savio E, Capella C, Pedrinis E, Saletti P, et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 1997, 26(5-6):527-537.
27. Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK, Patterson BJ, Ferreri AJ, Ponzoni M, Devizzi L, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003, 101(7):2489-2495. 10.1182/blood-2002-04-1279, 12456507.
28. Sonnen R, Schmidt WP, Muller-Hermelink HK, Schmitz N. The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas. Br J Haematol 2005, 129(3):366-372. 10.1111/j.1365-2141.2005.05478.x, 15842660.
29. Ruskone-Fourmestraux A, Aegerter P, Delmer A, Brousse N, Galian A, Rambaud JC. Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Groupe d'Etude des Lymphomes Digestifs. Gastroenterology 1993, 105(6):1662-1671.
30. Turowski GA, Basson MD. Primary malignant lymphoma of the intestine. Am J Surg 1995, 169(4):433-441. 10.1016/S0002-9610(99)80193-7, 7694986.
31. Lee J, Kim WS, Kim K, Ahn JS, Jung CW, Lim HY, Kang WK, Park K, Ko YH, Kim YH, et al. Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leuk Res 2007, 31(3):359-364. 10.1016/j.leukres.2006.06.018, 16930692.
32. Kim SJ, Kang HJ, Kim JS, Oh SY, Choi CW, Lee SI, Won JH, Kim MK, Kwon JH, Mun YC, et al. Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood 2011, 117(6):1958-1965. 10.1182/blood-2010-06-288480, 21148334.